Granbow, Valentini, and Armstrong patients (27 % ) had inflammatory heart disease. The other patients showed normal histology (eight patients, 36 % ) or increased fibrosis (seven patients, 32 % ), which was accompanied by pathologic lipomatosis in only three patients (14%). In the present study we often found significant fibrolipomatosis (66 % ), leading to the diagnosis of arrhythmogenic right ventricular dysplasia. This high incidence of right ventricular dysplasia may relate to the more extensive procedure used, which obviously may increase the likelihood of finding clinically significant microscopic abnormalities. It may be objected that the high incidence may have been the result of less strict pathoanatomic criteria, compared with those used by other investigators.3
In addition, lipomatosis may be considered to be a normal observation in endomyocardial right ventricular biopsies. However, in accordance with the report by Mehta et al.,ll we considered the presence of adipose tissue significant only when it was accompanied by an increase in fibrous tissue.
Identification of a specific cause of idiopathic ventricular fibrillation has consequences for diagnosis and prognosis. Patients with a reversible cause, such as inflammatory heart disease, may especially have a favorable prognosis. 6 On the other hand, the prognosis may be rather variable in patients with right ventricular dysplasia or other cardiomyopathies.
This explains the differences in prognosis of survivors of sudden death who have no cardiac disease in studies that did not use endomyocardial biopsies. The clinical value and feasibility of extensive right ventricular endomyocardial biopsy procedures in idiopathic ventricular fibrillation remain to be established in a larger cohort of patients. An extensive biopsy procedure could implicate a higher complication risk than a standard procedure, especially in the case of diseased right ventricles. During the biopsy procedures, care was taken to prevent deep transmural biopsies. The absence of complications in the present report may relate to the fact that biopsies were taken from patients in the early stages of the disease whose ventricular tissue was still relatively well preserved. Left ventricular mural thrombus is a frequent complication of acute myocardial infarction. Its occurrence has been reported after 15 % to 20 % of all myocardial infarctions and after 30% to 50% of anterior Q-wave infarctions. ' Embolit events in the first 4 months after myocardial infarction have been reported to occur in up to 30 % of patients with left ventricular mural thrombus in the absence of anticoagulation.2 Two-dimensional echocardiography is a sensitive and specific, noninvasive method of detecting left ventricular mural thrombus.3 Controversy exists as to whether the administration of thrombolytic therapy or the early use of intravenous heparin in acute myocardial infarction reduces the incidence of left ventricular mural thrombus formation.4-10 The purpose of this study was to determine whether the early use of aspirin and intravenous heparin, with or without thrombolytic therapy, alters the incidence of left ventricular mural thrombus in patients with acute myocardial infarction.
We reviewed the medical records of patients who were first seen between January 1990 and June 1991 at the University of Michigan Medical Center with chest pain and electrocardiographic and enzymatic evidence of acute myocardial infarction. The characteristics of the study population are shown in Table I . Attention was paid to the use of aspirin, intravenous heparin, and thrombolytic therapy within 12 hours of presentation. Patients given aspirin received a daily oral dose of 324 mg. Patients receiving intravenous heparin were given a bolus of 5000 units and started on a dose of 1000 U/hr. The dose of heparin was adjusted to maintain the activated partial thromboplastin time at 1.5 to 2 times control. Heparin was continued for 5.3 rt 3 days. Patients receiving thrombolytic therapy received 100 mg of tissue plasminogen activator intravenously over a period of 3 hours or 1.5 million U of streptokinase over a period of 1 hour. Each patient was subsequently managed in the coronary care unit in a standard manner. All patients underwent two-dimensional echocardiography with phased-array scanners during hospitalization 6.7 +-4.2 days after infarction. Echocardiograms were analyzed by two observers who were blinded to medical therapy. Left ventricular mural thrombus was diagnosed by means of the criteria of Asinger et al.,l in which an echo- Non-Q-wave infarction (n = 50) 4.0 dense mass originating from the endocardial surface in an area of regional asynergy is noted in two orthogonal views at various depth settings. Left ventricular ejection fraction was calculated by Simpson's rule from apical echocardiographic views or at cardiac catherization with a prolate llipse geometric model. Aspirin was given to 88% of patients, 83% received intravenous heparin, and 42% of patients received aspirin and heparin in addition to thrombolytic therapy. Thrombolytic therapy was administered to 70 (42 % ) patients. The time to lytic therapy was 3.7 + 2.2 hours after onset of chest pain in patients with thrombus and 4.0 + 2.9 hours in patients without thrombus. The overall incidence of left ventricular mural thrombus was 16%) with the highest incidence (32%) in anterior Q-wave infarctions (Table II) . All thrombi associated with anterior Q-wave infarctions and with non-Q-wave infarctions were found in the left ventricular apex and were associated with areas of asynergy. The two thrombi complicating inferior wall myocardial infarction were seen with posterior wall aneurysms. The frequency of aspirin and intravenous heparin use was similar in patients with and without left ventricular mural thrombus. Thrombolytic therapy did not reduce the incidence of left ventricular mural thrombus formation (Fig. 1) . Patients with left ventricular mural thrombus developing after anterior Q-wave infarction had lower left ventricular ejection fractions (29 % vs 43 % , p = O.OOOl), had a higher rate of in-hospital congestive heart failure or death (7 % vs 26 % , p = 0.0009), Bjerregaard et al. and tended to have higher postinfarction peak creatine kinase levels (2740 IU/L vs 2035 III/L, p = 0.09) (Table III) . Left ventricular mural thrombus was associated with akinesis or dyskinesis of the anteroapical wall in 89% of the cases. There was no difference in ejection fraction in patients with anterior Q-wave infarctions with (36.9 % ) or without (33%) thrombolytic therapy. No in-hospital embolic events were noted in any study patient.
Left ventricular mural thrombus formation after acute myocardial infarction is favored by stasis of blood and endocardial injury, both of which increase with greater extent of myocardial damage. Lysis or inhibition of thrombus formation on necrotic endocardial surfaces has been one proposed mechanism by which anticoagulants such as heparin or thrombolytic agents may reduce the incidence of left ventricular mural thrombus formation in acute myocardial infarction.4, 6 We did not observe a reduction in the incidence of left ventricular mural thrombus formation in patients receiving intravenous heparin, but the absence of embolic complications in our study population may be a result of the aggressive anticoagulation regimen used. Alternatively, reduction of infarct size with preservation of regional and overall left ventricular function has been suggested to be the primary mechanism by which thrombolytic therapy may reduce the incidence of left ventricular mural thrombus formation.5 The lack of reduction in incidence of left ventricular mural thrombus formation in patients receiving thrombolytic therapy noted in this study may be explained by the similarity in postinfarction wall motion and overall left ventricular function when compared with non-lytic-treated patients. The results of this study suggest that the incidence of left ventricular mural thrombus formation is not reduced by the use of aspirin and intravenous heparin, alone or in combination with thrombolytic therapy, when compared with historical controls when anteroapical wall motion and overall left ventricular function are not preserved, however, in-hospital embolic complications are rare.
